Liver transplantation for the patient with high MELD

Cynthia Wang, Randolph H. Steadman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The model for end-stage liver disease (MELD) is a system for scoring the severity of liver disease. The model was developed in 2000 to predict survival in patients undergoing transjugular intrahepatic portosystemic shunt placement. However, in 2002, the Organ Procurement and Transplantation Network adopted the MELD score as the standard for prioritization of graft allocation for liver transplantation [1-3]. With few exceptions (hepatocellular carcinoma and acute liver failure), those patients with highest MELD scores have the highest priority for organ allocation for orthotopic liver transplantation (OLT) in many countries including the United States. Since the implementation of the MELD system, wait-list mortality has significantly decreased, waiting time to liver transplantation has been reduced by over 100 days, and the MELD score has proven to be a good marker for 1-year posttransplantation survival [4-7]. The MELD score is a composite of three laboratory values: the international normalized ratio (INR) [8], serum creatinine, and serum bilirubin [9].

Original languageEnglish (US)
Title of host publicationLiver Anesthesiology and Critical Care Medicine
PublisherSpringer New York
Pages215-221
Number of pages7
ISBN (Electronic)9781461451679
ISBN (Print)9781461451662
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Liver transplantation for the patient with high MELD'. Together they form a unique fingerprint.

Cite this